▶ 調査レポート

帯状疱疹ワクチンの世界市場2020年:メーカー別、地域別、種類・用途別

GlobalInfoResearchが調査・発行した産業分析レポートです。帯状疱疹ワクチンの世界市場2020年:メーカー別、地域別、種類・用途別 /  / MRC2012A9730資料のイメージです。• レポートコード:MRC2012A9730
• 出版社/出版日:GlobalInfoResearch / 2020年12月28日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、106ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥522,000 (USD3,480)▷ お問い合わせ
  Multi User¥783,000 (USD5,220)▷ お問い合わせ
  Corporate User¥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、帯状疱疹ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。帯状疱疹ワクチンの種類別市場規模(生、組換え)、用途別市場規模(政府機関、民間部門、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):GSK、Merck、Sanofi Pasteur、
・地域別グローバル市場分析 2015年-2020年
・帯状疱疹ワクチンの北米市場(アメリカ、カナダ、メキシコ)
・帯状疱疹ワクチンのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・帯状疱疹ワクチンのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・帯状疱疹ワクチンの南米市場(ブラジル、アルゼンチン)
・帯状疱疹ワクチンの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:生、組換え
・用途別分析:政府機関、民間部門、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Zoster Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Zoster Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Zoster Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Zoster Vaccine market has been segmented into
Live
Recombinant

By Application, Zoster Vaccine has been segmented into:
Government Institution
Private Sector
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Zoster Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Zoster Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Zoster Vaccine market.

The report offers in-depth assessment of the growth and other aspects of the Zoster Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Zoster Vaccine Market Share Analysis
Zoster Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Zoster Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Zoster Vaccine sales, revenue and market share for each player covered in this report.

The major players covered in Zoster Vaccine are:
GSK
Merck
Sanofi Pasteur

Among other players domestic and global, Zoster Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Zoster Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Zoster Vaccine, with price, sales, revenue and global market share of Zoster Vaccine in 2018 and 2019.
Chapter 3, the Zoster Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Zoster Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Zoster Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Zoster Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Zoster Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Zoster Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Live
1.2.3 Recombinant
1.3 Market Analysis by Application
1.3.1 Overview: Global Zoster Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Overview of Global Zoster Vaccine Market
1.4.1 Global Zoster Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GSK SWOT Analysis
2.1.4 GSK Product and Services
2.1.5 GSK Zoster Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merck SWOT Analysis
2.2.4 Merck Product and Services
2.2.5 Merck Zoster Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi Pasteur
2.3.1 Sanofi Pasteur Details
2.3.2 Sanofi Pasteur Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi Pasteur SWOT Analysis
2.3.4 Sanofi Pasteur Product and Services
2.3.5 Sanofi Pasteur Zoster Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Zoster Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Zoster Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Zoster Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Zoster Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Zoster Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Zoster Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Zoster Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Zoster Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Zoster Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Zoster Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Zoster Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Zoster Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Zoster Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Zoster Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Zoster Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Zoster Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Zoster Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Zoster Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Zoster Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Zoster Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Zoster Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Zoster Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Zoster Vaccine Sales and Growth Rate (2015-2020)
6.4 France Zoster Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Zoster Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Zoster Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Zoster Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Zoster Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Zoster Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Zoster Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Zoster Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Zoster Vaccine Sales and Growth Rate (2015-2020)
7.5 India Zoster Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Zoster Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Zoster Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Zoster Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Zoster Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Zoster Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Zoster Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Zoster Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Zoster Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Zoster Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Zoster Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Zoster Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Zoster Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Zoster Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Zoster Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Zoster Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Zoster Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Zoster Vaccine Price by Type (2015-2020)
11 Global Zoster Vaccine Market Segment by Application
11.1 Global Zoster Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Zoster Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Zoster Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Zoster Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Zoster Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Zoster Vaccine Market Forecast (2021-2025)
12.2.2 Europe Zoster Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Zoster Vaccine Market Forecast (2021-2025)
12.2.4 South America Zoster Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Zoster Vaccine Market Forecast (2021-2025)
12.3 Zoster Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Zoster Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Zoster Vaccine Market Share Forecast by Type (2021-2025)
12.4 Zoster Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Zoster Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Zoster Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Zoster Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Zoster Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Zoster Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Zoster Vaccine Major Business
Table 9. GSK Zoster Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. GSK SWOT Analysis
Table 11. GSK Zoster Vaccine Product and Services
Table 12. GSK Zoster Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Zoster Vaccine Major Business
Table 15. Merck Zoster Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. Merck SWOT Analysis
Table 17. Merck Zoster Vaccine Product and Services
Table 18. Merck Zoster Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi Pasteur Zoster Vaccine Major Business
Table 21. Sanofi Pasteur Zoster Vaccine Total Revenue (USD Million) (2017-2018)
Table 22. Sanofi Pasteur SWOT Analysis
Table 23. Sanofi Pasteur Zoster Vaccine Product and Services
Table 24. Sanofi Pasteur Zoster Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Global Zoster Vaccine Sales by Manufacturer (2018-2019) (K Units)
Table 26. Global Zoster Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 27. Global Zoster Vaccine Sales by Regions (2015-2020) (K Units)
Table 28. Global Zoster Vaccine Sales Market Share by Regions (2015-2020)
Table 29. Global Zoster Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 30. North America Zoster Vaccine Sales by Countries (2015-2020) (K Units)
Table 31. North America Zoster Vaccine Sales Market Share by Countries (2015-2020)
Table 32. North America Zoster Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 33. North America Zoster Vaccine Revenue Market Share by Countries (2015-2020)
Table 34. Europe Zoster Vaccine Sales by Countries (2015-2020) (K Units)
Table 35. Europe Zoster Vaccine Sales Market Share by Countries (2015-2020)
Table 36. Europe Zoster Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 37. Asia-Pacific Zoster Vaccine Sales by Regions (2015-2020) (K Units)
Table 38. Asia-Pacific Zoster Vaccine Sales Market Share by Regions (2015-2020)
Table 39. Asia-Pacific Zoster Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 40. South America Zoster Vaccine Sales by Countries (2015-2020) (K Units)
Table 41. South America Zoster Vaccine Sales Market Share by Countries (2015-2020)
Table 42. South America Zoster Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 43. South America Zoster Vaccine Revenue Market Share by Countries (2015-2020)
Table 44. Middle East & Africa Zoster Vaccine Sales by Countries (2015-2020) (K Units)
Table 45. Middle East & Africa Zoster Vaccine Sales Market Share by Countries (2015-2020)
Table 46. Middle East & Africa Zoster Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 47. Middle East & Africa Zoster Vaccine Revenue Market Share by Countries (2015-2020)
Table 48. Global Zoster Vaccine Sales by Type (2015-2020) (K Units)
Table 49. Global Zoster Vaccine Sales Share by Type (2015-2020)
Table 50. Global Zoster Vaccine Revenue by Type (2015-2020) (USD Million)
Table 51. Global Zoster Vaccine Revenue Share by Type (2015-2020)
Table 52. Global Zoster Vaccine Sales by Application (2015-2020) (K Units)
Table 53. Global Zoster Vaccine Sales Share by Application (2015-2020)
Table 54. Global Zoster Vaccine Sales Forecast by Regions (2021-2025) (K Units)
Table 55. Global Zoster Vaccine Market Share Forecast by Regions (2021-2025)
Table 56. Global Zoster Vaccine Sales Forecast by Type (2021-2025) (K Units)
Table 57. Global Zoster Vaccine Market Share Forecast by Type (2021-2025)
Table 58. Global Zoster Vaccine Sales Forecast by Application (2021-2025)
Table 59. Global Zoster Vaccine Market Share Forecast by Application (2021-2025)
Table 60. Direct Channel Pros & Cons
Table 61. Indirect Channel Pros & Cons
Table 62. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Zoster Vaccine Picture
Figure 2. Global Sales Market Share of Zoster Vaccine by Type in 2019
Figure 3. Live Picture
Figure 4. Recombinant Picture
Figure 5. Zoster Vaccine Sales Market Share by Application in 2018
Figure 6. Government Institution Picture
Figure 7. Private Sector Picture
Figure 8. Other Picture
Figure 9. Global Zoster Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Zoster Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Zoster Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Zoster Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Zoster Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Zoster Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Zoster Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Zoster Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Zoster Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Zoster Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Zoster Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Zoster Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Zoster Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Zoster Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Zoster Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Zoster Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Zoster Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Zoster Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Zoster Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Zoster Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Zoster Vaccine Sales Market Share by Manufacturer in 2019
Figure 30. Global Zoster Vaccine Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Zoster Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Zoster Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Zoster Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Zoster Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Zoster Vaccine Revenue Market Share by Regions (2015-2020)
Figure 37. Global Zoster Vaccine Revenue Market Share by Regions in 2018
Figure 38. North America Zoster Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Europe Zoster Vaccine Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Zoster Vaccine Sales and Growth Rate (2015-2020)
Figure 41. South America Zoster Vaccine Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Zoster Vaccine Sales and Growth Rate (2015-2020)
Figure 43. North America Zoster Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Zoster Vaccine Sales Market Share by Countries (2015-2020)
Figure 45. North America Zoster Vaccine Sales Market Share by Countries in 2018
Figure 46. North America Zoster Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Zoster Vaccine Revenue Market Share by Countries in 2018
Figure 48. United States Zoster Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Zoster Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Zoster Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Zoster Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Zoster Vaccine Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Zoster Vaccine Revenue Market Share by Countries in 2019
Figure 54. Germany Zoster Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Zoster Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Zoster Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Zoster Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Zoster Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Zoster Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Zoster Vaccine Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Zoster Vaccine Revenue Market Share by Regions 2019
Figure 62. China Zoster Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Zoster Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Zoster Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Zoster Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Zoster Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Zoster Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Zoster Vaccine Sales Market Share by Countries in 2019
Figure 69. South America Zoster Vaccine Revenue Market Share by Countries in 2019
Figure 70. Brazil Zoster Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Zoster Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Zoster Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Zoster Vaccine Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Zoster Vaccine Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Zoster Vaccine Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Zoster Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Zoster Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Zoster Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Zoster Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Zoster Vaccine Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Zoster Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Zoster Vaccine Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Zoster Vaccine Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Zoster Vaccine Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Zoster Vaccine Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Zoster Vaccine Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel